Abstract
Rosacea is a chronic, inflammatory skin disease that primarily affects the centrofacial region (cheeks, nose, chin, forehead) and eyes, characterized and diagnosed by recurrent flushing episodes, persistent erythema, inflammatory papules and/or pustules and telangiectasia. It cannot be cured, only "kept under control" by avoiding the causing factors, use of oral and/or topical drugs, appropriate cosmetic products and application of certain cosmetic treatments. Regarding the treatment of rosacea with pronounced inflammatory papules and pustules, the most common dermatological approach is the use of topical preparations with azelaic acid, while for the same indication in cosmetic procedures superficial azelaic chemical peeling is performed. The aim of this study was to evaluate the effectiveness of a new approach in the treatment of papulopustular rosacea - a combined application of superficial chemical peels with 20% azelaic acid and facial oxygen therapy. The client, 45 years old, female, diagnosed with papulopustular (PP) rosacea, diffuse erythema and PP lesions on the cheeks, forehead and chin, without pharmacological therapy, underwent superficial chemical peel treatment with 20% azelaic acid. The solution was applied to the PP lesions region, neutralized and hydraporation was performed with oxygen jet and hyaluronic acid serum, for 10 minutes. Seven days after the treatment, there were a reduction of inflammatory papules and pustules of the centrofacial region, reduction of erythema and improvement of the skin appearance. Skin condition, with adequate skin care advice, remained unchanged even after three months. Mentioned approach could be successfully in the treatment of mild to moderate papulopustular rosacea.
References
Del Rosso JQ, Tanghetti E, Webster G, Gold LS, Thiboutot D, Gallo RL. Update on the management of rosacea from the American Acne & Rosacea Society (AARS). J. Clin. Aesthet. Dermatol. 2020; 13(6 Suppl): S17-S24.
Dall’Oglio F, Tedeschi A, Lacarrubba F, Fabbrocini G, Skroza N, Chiodini P, Micali G. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial. J Cosmet. Dermatol. 2021; 20: 28-31.
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).